|
|
Volumn 25, Issue 103, 1996, Pages 89-90
|
|
Efficacy and safety of menorest (50 Mikrog/Day) compared to premarin 0.625 mg in the treatment of menopausal symptoms and the prevention of bone loss, in menopausal women. A single-center, comparative, randomized, double-blind, double-dummy study
a
a
a
|
|
Author keywords
Bone density; Menopausal symptoms; Oestrogen plaster; Oestrogen replacement therapy
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CONJUGATED ESTROGEN;
DYDROGESTERONE;
ESTRADIOL;
ESTROGEN;
BONE ATROPHY;
BONE DENSITY;
BONE MINERAL;
BREAST CARCINOMA;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORTICAL BONE;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG SAFETY;
ESTROGEN THERAPY;
FEMALE;
HIP;
HOT FLUSH;
HUMAN;
LONG TERM CARE;
LUMBAR SPINE;
MASTALGIA;
MENOPAUSAL SYNDROME;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SKIN MANIFESTATION;
TRABECULAR BONE;
TRANSDERMAL DRUG ADMINISTRATION;
ARTICLE;
COMPARATIVE STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
FLUSHING;
MENOPAUSE;
PILOT STUDY;
POSTMENOPAUSE OSTEOPOROSIS;
BONE DENSITY;
DOUBLE-BLIND METHOD;
DYDROGESTERONE;
ESTRADIOL;
ESTROGENS, CONJUGATED (USP);
FEMALE;
FLUSHING;
HUMANS;
MENOPAUSE;
OSTEOPOROSIS, POSTMENOPAUSAL;
PILOT PROJECTS;
|
|
EID: 0029704302
PISSN: 03013847
EISSN: None
Source Type: Journal
DOI: 10.3109/03009749609103759 Document Type: Conference Paper |
|
Times cited : (5)
|
|
References (0)
|
